News

Infinity Laboratories has gone on to achieve successful accreditation across all its sites pertaining to their ISO/IEC standards, thereby highlighting its commitment to making sure that high standards of excellence and quality within the field of chemical and microbiology...

It is worth noting that 84% of pharma and healthcare companies go on to consider that the new EU Corporate Sustainability Due Diligence Directive- CDDDD happens to be nothing short of an opportunity so as to sync human rights...

The Drug, Chemical, & Associated Technologies Association- DCAT has gone on to recently release a study from DCAT Research & Benchmarking- The emerging role of Artificial Intelligence in Supply Chain Management. The fact is that the bio- and pharma sectors...

TriLink BioTechnologies, a Maravai LifeSciences company and global provider of life science reagents and services, has joined forces with Johns Hopkins University to accelerate transformational research in RNA therapeutics and discovery by establishing a new center within the Johns...

Life science group Sartorius is collaborating with biopharmaceutical company Sanofi to develop an end-to-end platform for integrated and continuous downstream bioprocessing (ICB). Integrated continuous biomanufacturing is an advanced approach to the production of biopharmaceuticals, which aims to maximize efficiency by...

AbbVie and Gilgamesh Pharmaceuticals entered a collaboration and option-to-license agreement to develop next-generation therapies for psychiatric disorders. This collaboration will leverage AbbVie's expertise in psychiatry and Gilgamesh's research platform to discover novel neuroplastogens. Under the agreement, the companies have agreed...

Boehringer Ingelheim has entered an agreement with Quallent Pharmaceuticals, a private label pharmaceutical distributor, to help expand patient access to citrate-free adalimumab-adbm, Boehringer's biosimilar to Humira (adalimumab), in the U.S. Under the terms of the agreement, Boehringer Ingelheim will manufacture...